Takeda
Pharma

Takeda swings to loss for '25 with hefty jury verdict

The company adjusted its full-year 2025 earnings to account for a legal provision of 402.5 billion JPY ($2.5 billion).
Zoey Becker Jun 5, 2026 11:30am
mifepristone

FDA is moving forward with abortion pill safety study: WSJ

Jun 5, 2026 11:06am
The Top Line

Behind the headlines of ASCO 2026

Jun 5, 2026 9:38am
Food and Drug Administration

Regulatory tracker: AbbVie's Elahere cleared for use in England

Jun 5, 2026 9:25am
FDA
Favicon Fierce Biotech

At CNPV hearing, industry support meets ‘concern’ from experts

Jun 5, 2026 5:00am
The Supreme Court building

In a big win for generics drugmakers, SCOTUS sides with Hikma

Jun 4, 2026 3:11pm
More News

Patient deaths raise questions about ADC's cancer drug Zynlonta

Jun 4, 2026 11:38am
Fierce Biotech

A divisive bill seeks to limit biotech investment in China

Jun 4, 2026 10:54am

Axsome bars generic rivals to narcolepsy med Sunosi until 2040

Jun 4, 2026 9:35am

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm